Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

hierarchy

書目名稱Cancer Immunology影響因子(影響力)




書目名稱Cancer Immunology影響因子(影響力)學(xué)科排名




書目名稱Cancer Immunology網(wǎng)絡(luò)公開度




書目名稱Cancer Immunology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Immunology被引頻次




書目名稱Cancer Immunology被引頻次學(xué)科排名




書目名稱Cancer Immunology年度引用




書目名稱Cancer Immunology年度引用學(xué)科排名




書目名稱Cancer Immunology讀者反饋




書目名稱Cancer Immunology讀者反饋學(xué)科排名

結(jié)構(gòu)

R. Achatzy,F. Daschner,N. Pittlik,F. Bartelsd encouraging results have been demonstrated both preclinically and in clinical trials. In this chapter we summarize the immunotherapeutic strategies for multiple myeloma together with the most up-to-date clinical trial outcomes.

高腳酒杯

B. Roth,G. Mattarelli,F. Bartelsoverview of candidate antigens to target in AML is given, followed by the currently described passive and active immunotherapeutic strategies. Active immunotherapy (e.g., modified leukemic cells, peptide, DNA, or dendritic cell-based vaccinations) requires a patient with an intact immune system and

ITCH

狂熱語言

性別

Joachim H.R. Lübke,Astrid Rollenhagennogenesis and progression has been unveiled. Cytokines and lymphokines such as interleukin-6 and lymphotoxin, together with immune cells such as tumor-associated macrophages, play an important role in this process. Disruption in normal immune regulatory mechanisms provides additional therapeutic tar

性別

Joachim H.R. Lübke,Astrid Rollenhagenhocytes (Treg). The present knowledge of the tumor microenvironment at the molecular and cellular levels is being used to reverse the situation in favor of the patient through targeted therapies such as the use of tyrosine kinase inhibitors or procedures that specifically activate an immune reaction

希望

Individual

Martin Middeke,Heinrich Holzgrevemor rejection rather than tolerance. This chapter will provide an overview of the immunomodulatory effects of nonsteroidal anti-inflammatory drugs (NSAIDs), statins, selective estrogen response modulators (SERMs), rexinoids, antidiabetic drugs, and natural agents (triterpenoids, phytochemicals, fatt

鋼筆尖

Joseph A. Ball,Israel Gohberg,Leiba Rodmannt treatment options and are held responsible for the initiation, metastasis, and recurrence of the disease. Thus, investigations on the interaction of CSCs with the host immune system have been performed, and targeting CSCs will potentially result in improved therapeutic outcome in the future.